Home › Lupus Nephritis › Colorado
Lupus Nephritis clinical trials in Colorado
7 studies for Lupus Nephritis are looking for participants at sites in Colorado.
Cities in Colorado
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- University of Colorado Denver, Aurora
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Oct 1, 2026 · NCT05268289VIBRANT: VIB4920 for Active Lupus Nephritis
- University of Colorado School of Medicine: Division of Rheumatology, Aurora
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05201469The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Children's Hospital Colorado, Aurora
RecruitingPhase 2
Ages 8 to 20 · All sexes · Updated Sep 14, 2026 · NCT05538208A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Colorado Denver, Aurora
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Children's Hospital Colorado, Anchutz Medical Campus, Aurora
RecruitingPhase 2
Ages 5 to 17 · All sexes · Updated Sep 3, 2026 · NCT05039619PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Western Nephrology & Metabolic Bone Disease, PC, Arvada
RecruitingPhase 4
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07611214A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- University of Colorado, Denver, Denver
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 11, 2026 · NCT07403188From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.